Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00529451
Status:
COMPLETED
Last Update Posted:
2011-03-25
First Post:
2007-09-12
Brief Title:
Safety and Efficacy of Aliskiren 300 mg 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CSPP100A2339
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
External Affairs
Old Organization:
Novartis